FDA Delays Launch Of Antares Pharma Low T Drug

New Testosterone Treatment Delayed By FDA The scheduled release of new low testosterone drug Quickshot by Antares Pharma has been delayed by the FDA.. The unplanned delay has occurred because the FDA uncovered reports of a test subject experiencing hives after being treated with the experimental drug.. The makers – Antares Pharma do not believe … Read moreFDA Delays Launch Of Antares Pharma Low T Drug